Author

Jan‐Georg Wojtyniak

Observed names: Jan-Georg Wojtyniak, Wojtyniak Jan‐Georg, Wojtyniak, Jan-Georg

Observed institutions: Boehringer Ingelheim (Germany), Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Saarland University

ORCID: 0000-0003-1304-9033

Observed ORCID: 0000-0003-1304-9033

OpenAlex ID: A5037819335

Data Digitizing: Accurate and Precise Data Extraction for Quantitative Systems Pharmacology and Physiologically‐Based Pharmacokinetic Modeling

2020 · Jan‐Georg Wojtyniak, Hannah Britz, et al. · CPT Pharmacometrics & Systems Pharmacology · 108

How to disentangle psychobiological stress reactivity and recovery: A comparison of model-based and non-compartmental analyses of cortisol concentrations

2017 · Robert Miller, Jan-Georg Wojtyniak, et al. · Psychoneuroendocrinology · 68

Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy

2018 · Maximilian A. Ardelt, Thomas Fröhlich, et al. · Hepatology · 58

Pharmacokinetics of (synthetic) cannabinoids in pigs and their relevance for clinical and forensic toxicology

2016 · Nadine Schaefer, Jan-Georg Wojtyniak, et al. · Toxicology Letters · 44

Physiologically Based Precision Dosing Approach for Drug‐Drug‐Gene Interactions: A Simvastatin Network Analysis

2020 · Jan‐Georg Wojtyniak, Dominik Selzer, et al. · Clinical Pharmacology & Therapeutics · 38

A Physiologically Based Pharmacokinetic Model of Ketoconazole and Its Metabolites as Drug–Drug Interaction Perpetrators

2023 · Fatima Zahra Marok, Jan-Georg Wojtyniak, et al. · Pharmaceutics · 26

Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions

2020 · Simeon Rüdesheim, Jan-Georg Wojtyniak, et al. · Pharmaceutics · 25

A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin—integration of in vitro results, Phase I and Phase II data and model application for drug–drug interaction potential analysis

2017 · Nina Hanke, Michael Teifel, et al. · Cancer Chemotherapy and Pharmacology · 23

Personalized Chronomodulated 5‐Fluorouracil Treatment: A Physiologically‐Based Pharmacokinetic Precision Dosing Approach for Optimizing Cancer Therapy

2024 · Fatima Zahra Marok, Jan‐Georg Wojtyniak, et al. · Clinical Pharmacology & Therapeutics · 14

Can toxicokinetics of (synthetic) cannabinoids in pigs after pulmonary administration be upscaled to humans by allometric techniques?

2018 · Nadine Schaefer, Jan-Georg Wojtyniak, et al. · Biochemical Pharmacology · 14

Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon

2018 · Michael Ramharter, Matthias Schwab, et al. · Antimicrobial Agents and Chemotherapy · 6

Pharmacokinetics and pharmacodynamics of empagliflozin in paediatric patients aged 10–17 years with type 2 diabetes mellitus

2025 · Juliane Rascher, Shen Cheng, et al. · British Journal of Clinical Pharmacology · 4

Poster presented at PAGE 2026. The Decision-Equivalence Metric (DEM) Method Based Evaluation of Biomarker Surrogacy in MASH

2026 · Vasyutin, Igor, Stübler, Sabine, et al. · Figshare

Works count: 14

Citation count: 428

H-index: 10

I10-index: 10